home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

7th Annual Peptides & Oligonucleotides Congress

 
  November 05, 2019  
     
 
Oxford Global, Novotel London West, 1 Shortlands, Hammersmith International Ctre, Hammersmith, W6 8DR, London, UK
27 - 29 April 2020


Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery & development of oligonucleotide therapeutics, manufacturing and process development.

 

View Agenda: https://bit.ly/2PP4A5V

 

27 April 2019 – Day One (Kick-off Session)

  • Turning Challenges to Successes in Peptides Delivery & Formulation

 

28 April 2020 – Day Two

  • Peptide Design, Synthesis, Purification & Analytical Technologies
  • Peptide Manufacturing & Process Development
  • Oligonucleotide Synthesis, Chemistry, Formulation & Delivery, Process & Analytical Development

 

29 April 2020 – Day Three

  • Peptide Therapeutics: Case Studies, Immunogenicity & Novel Disease Treatments
  • Oligonucleotide Therapeutics & Manufacturing

 

2020 Live Webinar

Targeted, Controlled and Responsive Therapeutic Delivery through the Design of Self-Assembling Peptide Hydrogels

Presented by Aline Miller, Professor, University of Manchester

Register: https://bit.ly/2pzwpV9

 

  • Design rules for engineering responsive peptide hydrogels
  • Targeting endometriosis with sprayable peptide hydrogels
  • Delivery of therapeutics to solid tumours
  • Mucoadhesive hydrogels to prolong therapeutic efficacy

 

 
 
Organized by: Oxford Global
Invited Speakers:
  • Gene Liau, Executive Vice President and Head, Research & Preclinical Development, Stoke Therapeutics
  • Ekkehard Leberer, Senior Director, Sanofi
  • Matthew Catley, Research Director, MiNA Therapeutics
  • Jennifer Franklin, Director, CMC Regulatory Affairs, IONIS Pharmaceuticals
  • Michael Agrez, Chief Executive Officer, InterK Peptide Therapeutics
  • David Earp, President and Chief Executive Officer, Circle Pharma
  • Ali Tavassoli, Founder and Chief Scientific Officer, Curve Therapeutics
  • Olivier Kitten, Founder and Chief Executive Officer, Affilogic
  • Alex Batchelor, Chief Executive Officer, Orbit Discovery
  • Els Beirnaert, Chief Executive Officer, Aelin Therapeutics
  • Andrew Young, Chief Scientific Officer, Intarcia Therapeutics
  • & many more

 

 
Deadline for Abstracts: N/A
 
Registration: https://bit.ly/369yLKG
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2019 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.